Outlive
Photo by Pema Gyamtsho / Unsplash

Outlive

A comprehensive coaching service, where we help you directly with the implementation of the Mosaic Method into your life.


Share this post

Cancer is an exceedingly complex disease with many different manifestations. There is no one-size-fits-all solution to it. However, current standard care is mostly unable to account for this and is limited to institutionally approved treatments. It lags behind research and omits the utilisation of complementary therapies. Because of this, cancer in most cases is still a death sentence with little hope of healing.

On top of this, patients are usually just provided with treatment and then sent home to deal with the disease on their own. You might even have experienced this yourself. There is no one showing you with what you can do on your own to fight against cancer at home and there is no one to answer any of the questions you have.

This is where we want to help. Our mission is to spread knowledge about cancer, to eliminate uncertainty around it, and to help patients take the fight into their own hands. However, there is only so much detail we can get into when writing articles or making videos.

So for those who want more support, we offer personalised coaching.

In one-on-one sessions, we develop a complimentary treatment strategy together with you and tailored to your disease and situation. We will go over research, promising intervention beside standard care, tools for implementation into your life, as well as answer any questions arising along the way.

This way, we aim to remove the uncertainty, improve your quality of life and improve your chances, so that you have more quality time to do what you love with the people you love.

So far, our coaching has helped with

  • Multiply metastatic prostate cancer: reversion of bone metastases to young functional bone tissue, life expectancy raised from under 18 months to over 5 years within 7 months.
  • Multiply metastatic, malignant pleural mesothelioma: no life expectancy at diagnosis due to uncertainty, median overall survival of pleural mesothelioma patients ranging from 10 months to 58 months depending on study populations, treatments, stage at diagnosis, and other factors,1–5 patient currently alive and thriving 4 years after the initial diagnosis.

Additionally, we recently began working with a patient suffering from thrombocythaemic polycythaemia vera. Due to the recency, however, we do not feel that the results are significant enough to warrant publishing.

Now, we would love to guarantee that within a year of working with us, you will be healed or see equally good results as our previous clients. But we are dealing with biology and cancer, where there are no 100%. We simply cannot make such a guarantee to you without lying to you. And lying is not something we do.

However, whilst we cannot guarantee that you will achieve exactly the same results, we can guarantee that you will receive the same level of service. To that end, we offer a money-back guarantee. If you are not convinced of our service, within 2 sessions of your purchase, you can request a full refund, no questions asked.

If you are interested in a strategy tailored to your disease, support on its implementation, and answers to any questions you might have, you can book a discovery call below.


References

  1. Milano MT, Zhang H. Malignant Pleural Mesothelioma: A Population-Based Study of Survival. Journal of Thoracic Oncology. 2010;5(11):1841–8.
  2. Survival statistics for mesothelioma | Canadian Cancer Society [Internet]. [cited 2025 Oct 21]. Available from: https://cancer.ca/en/cancer-information/cancer-types/mesothelioma/prognosis-and-survival/survival-statistics
  3. Rahouma M, Aziz H, Ghaly G, Kamel M, Loai I, Mohamed A. Survival in Good Performance Malignant Pleural Mesothelioma Patients; Prognostic Factors and Predictors of Response. Asian Pac J Cancer Prev. 2017;18(8):2073–8.
  4. Milano MT, Zhang H. Malignant Pleural Mesothelioma: A Population-Based Study of Survival. Journal of Thoracic Oncology. 2010;5(11):1841–8.
  5. Amin W, Linkov F, Landsittel DP, Silverstein JC, Bshara W, Gaudioso C, et al. Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort. F1000Res. 2019 June 3;7:1184.